share_log

G1 Therapeutics Q4 EPS $(0.67) Beats $(0.87) Estimate, Sales $16.55M Beat $4.06M Estimate

G1 Therapeutics Q4 EPS $(0.67) Beats $(0.87) Estimate, Sales $16.55M Beat $4.06M Estimate

G1 Treeutics第四季度每股收益(0.67美元)超過預期(0.87美元)，銷售額1655萬美元超過預期406萬美元
Benzinga Real-time News ·  2021/02/25 05:12

G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.87) by 22.99 percent. This is a 28.72 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $16.55 million which beat the analyst consensus estimate of $4.06 million by 307.54 percent.

G1治療公司(納斯達克：GTHX)公佈季度虧損為每股0.67美元，比分析師普遍預期的(0.87美元)高出22.99%。這比去年同期每股虧損0.94美元增加了28.72%。該公司公佈季度銷售額為1,655萬美元，比分析師普遍預期的406萬美元高出307.54個百分點。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論